日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

替诺福韦艾拉酚胺 (TAF) 和富马酸替诺福韦二吡呋酯 (TDF) 序贯 TAF 治疗 5 年后,对东亚裔慢性乙型肝炎患者的疗效和安全性进行评估

Wong, Grace Lai-Hung; Gane, Edward; Pan, Calvin Q; Fung, Scott; Ma, Mang M; Izumi, Namiki; Shalimar; Lim, Seng Gee; Chuang, Wan-Long; Mehta, Rajiv; Lim, Young-Suk; Yee, Leland J; Flaherty, John F; Abramov, Frida; Wang, Hongyuan; Buti, Maria

Featured intestinal microbiota associated with hepatocellular carcinoma in various liver disease states

不同肝病状态下与肝细胞癌相关的肠道菌群特征

Sun, Xiu; Zhou, Zhewen; Chi, Xin; Cheng, Danying; Zhang, Yuanyuan; Xu, Yifan; Hao, Yanxu; Duan, Ying; Li, Wei; Zhao, Yingying; Liu, Shunai; Han, Ming; Wang, Xi; Yang, Song; Pan, Calvin Q; Xing, Huichun

Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review

非酒精性脂肪性肝病肌少症的临床特征:系统性范围综述

Ye, Tingdan; Mi, Ke; Zhu, Lin; Li, Jonathan; Pan, Calvin Q

Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD

对非肝硬化合并MASLD患者进行风险分层肝细胞癌监测

Mi, Ke; Ye, Tingdan; Zhu, Lin; Pan, Calvin Q

Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial

替诺福韦与妊娠期乙型肝炎病毒传播:一项随机临床试验

Pan, Calvin Q; Dai, Erhei; Mo, Zhongfu; Zhang, Hua; Zheng, Thomas Q; Wang, Yuming; Liu, Yingxia; Chen, Tianyan; Li, Suwen; Yang, Cuili; Wu, Jinjuan; Chen, Xiuli; Zou, Huaibin; Mei, Shanshan; Zhu, Lin

Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

长期使用替诺福韦艾拉酚胺治疗慢性乙型肝炎可获得较高的病毒抑制率,且肾脏和骨骼安全性良好。

Chan, Henry L Y; Buti, Maria; Lim, Young-Suk; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia; Chuang, Wan-Long; Janssen, Harry L A; Fung, Scott; Izumi, Namiki; Abdurakhmanov, Dzhamal; Jabłkowski, Maciej; Celen, Mustafa K; Ma, Xiaoli; Caruntu, Florin; Flaherty, John F; Abramov, Frida; Wang, Hongyuan; Camus, Gregory; Osinusi, Anu; Pan, Calvin Q; Shalimar; Seto, Wai-Kay; Gane, Edward

Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis

恩替卡韦治疗乙型肝炎合并失代偿期肝硬化患者的疗效持久性和治疗期间的再代偿预测因素

Deng, You; Kang, Haiyan; Xiang, Huiling; Nan, Yuemin; Hu, Jinhua; Meng, Qinghua; Zhao, Hong; Wang, Qi; Fang, Jilian; Xu, Jie; Wang, Xiaoming; Pan, Calvin Q; You, Hong; Xu, Xiaoyuan; Xie, Wen; Jia, Jidong

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis

替诺福韦艾拉酚胺与富马酸替诺福韦酯预防慢性乙型肝炎母亲母婴垂直传播的疗效比较:系统评价和荟萃分析

Pan, Calvin Q; Zhu, Lin; Yu, Andy S; Zhao, Yuchan; Zhu, Bo; Dai, Erhei

Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials

替诺福韦艾拉酚胺治疗慢性乙型肝炎病毒感染的八年疗效和安全性:两项随机3期试验的最终结果

Buti, Maria; Lim, Young-Suk; Chan, Henry Lik Yuen; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia R; Chuang, Wan-Long; Janssen, Harry L A; Fung, Scott K; Izumi, Namiki; Jablkowski, Maciej S; Abdurakhmanov, Dzhamal; Abramov, Frida; Wang, Hongyuan; Botros, Irina; Yee, Leland J; Mateo, Roberto; Flaherty, John F; Osinusi, Anu; Pan, Calvin Q; Shalimar, X; Seto, Wai-Kay; Gane, Edward J

Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor's clothes of normal liver enzymes?

代谢功能障碍相关脂肪肝疾病筛查:是时候揭开正常肝酶的神秘面纱了吗?

Huang, Chen-Xiao; Zhou, Xiao-Dong; Pan, Calvin Q; Zheng, Ming-Hua